Tenofovir-Containing Antiretroviral Therapy and Clinical Outcomes of SARS-CoV-2 Infection in People Living with HIV

Tenofovir has been hypothesized to be effective against COVID-19 and is available as two prodrugs, tenofovir disoproxil fumarate (TDF) and tenofovir alafenamide (TAF), both part of antiretroviral therapy (ART) regimens. People living with human immunodeficiency virus (PLWH) might be at higher risk f...

Descripción completa

Detalles Bibliográficos
Autores principales: Rombini, María F., Cecchini, Diego, Diana Menendez, Sofía, Calanni, Liliana, Cuini, Rosana, Obieta, Elena, Greco, María M., Morales, Fabricio, Morganti, Laura, Migazzi, Claudia, El Kozah, Yasmin, Parenti, Pablo, Cassetti, Isabel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10223653/
https://www.ncbi.nlm.nih.gov/pubmed/37243213
http://dx.doi.org/10.3390/v15051127

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10223653/
https://www.ncbi.nlm.nih.gov/pubmed/37243213
http://dx.doi.org/10.3390/v15051127

Ejemplares similares